510(k) Report

510(k) · Cleared

Recalled · 2010

Solution Administration Sets with Capless Luer Activated Valve

K003225510(k) SpecialCleared Oct 19, 20003-day reviewClass II21 CFR 880.5440Recalls 18

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Baxter Healthcare Corp · FPA Set, Administration, Intravascular

Cleared on Oct 19, 2000 after a 3-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 2 of the 51 devices in its family, counting itself, have a Class I recall. 50 later devices descend from it. It has been recalled 18 times.

Decided
Oct 19, 2000
Review
3 days
Class
Class II
Product code
FPA
Recalls
18
Predicates
0

50 later devices descend from it, 5 citing it directly. 2 of the 51 devices in this family, counting this one, have a Class I recall.

Descendants, by year cleared 2011: 2 descendants cleared, 1 with a Class I recall12007: 1 descendant cleared2012: 1 descendant cleared2004: 1 descendant cleared2016: 2 descendants cleared2005: 1 descendant cleared2015: 1 descendant cleared2009: 1 descendant cleared2008: 1 descendant cleared2014: 3 descendants cleared2019: 3 descendants cleared2021: 8 descendants cleared2022: 2 descendants cleared2020: 3 descendants cleared2013: 2 descendants cleared2010: 1 descendant cleared2017: 4 descendants cleared2025: 4 descendants cleared, 1 with a Class I recall12023: 6 descendants cleared2026: 2 descendants cleared2024: 1 descendant cleared200020052010201520202025
  1. This deviceK003225 Solution Administration Sets with Capless Luer Activated ValveBaxter Healthcare Corp · 2000
  2. Descendant · cites it directly · 28 of its ownK120443 Neutral Luer Activated Device and Extension Sets with Neutral Luer…Baxter Healthcare Corporation - Renal Division · 2012
  3. Descendant · 2 generations on · 26 of its ownK132413 MZ1000Care Fusion · 2013
  4. Descendant · 3 generations on · 13 of its ownK140831 Maxzero Extension Set with Needless ConnectorCare Fusion · 2014
  5. Descendant · cites it directly · 11 of its ownK112893 Clearlink Luer Activated Valve, Clearlink System Non-Dehp Catheter…Baxter Healthcare Corporation · 2011 · Recalled (Class I)
  6. Descendant · 3 generations on · 6 of its ownK170336 BD Nexiva Closed IV Catheter System (Single Port) with MaxZero…Becton, Dickinson and Company · 2017

Showing 5 of 50 descendants. See all descendants

Descendants cleared per year

2004: 12005: 12007: 12008: 12009: 12010: 12011: 22012: 12013: 22014: 32015: 12016: 22017: 42019: 32020: 32021: 82022: 22023: 62024: 12025: 42026: 2
2004high 8 (2021) · low 0 (2006)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 50 · See all
  • K120443Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated DeviceBaxter Healthcare Corporation - Renal Division · 2012 · cites it directly28descendants
  • K132413MZ1000Care Fusion · 2013 · 2 generations on26descendants
  • K140831Maxzero Extension Set with Needless ConnectorCare Fusion · 2014 · 3 generations on13descendants
  • K112893Clearlink Luer Activated Valve, Clearlink System Non-Dehp Catheter Extension SetsBaxter Healthcare Corporation · 2011 · cites it directly11descendants
  • K170336BD Nexiva Closed IV Catheter System (Single Port) with MaxZero Needleless ConnectorBecton, Dickinson and Company · 2017 · 3 generations on6descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K003225Solution Administration Sets with Capless Luer Activated ValveBaxter Healthcare Corp2000—
+1K120443Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated…Baxter Healthcare Corporation - Renal Division2012—
+2K132413MZ1000Care Fusion2013—
+3K140831Maxzero Extension Set with Needless ConnectorCare Fusion2014—
+1K112893Clearlink Luer Activated Valve, Clearlink System Non-Dehp Catheter Extension…Baxter Healthcare Corporation2011Class I
+3K170336BD Nexiva Closed IV Catheter System (Single Port) with MaxZero Needleless…Becton, Dickinson and Company2017—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200510
200710
200810
200910
201010
201121
201210
201320
201430
201510
201620
201740
201930
202030
202180
202220
202360
202410
202541
202620
FIG. 1 — Lineage of K003225, 2000–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (50)

See all 50

5 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K120443Neutral Luer Activated Device and Extension Sets with Neutral Luer Activated DeviceBaxter Healthcare Corporation - Renal Division201228
K112893Clearlink Luer Activated Valve, Clearlink System Non-Dehp Catheter Extension Sets Class IBaxter Healthcare Corporation201111
K072576Clearlink Antimicrobial Luer Activated Device (Lad) and Extension Sets with the…Baxter Healthcare Corp20074
K040385Multiport Manifold Set with Swabable Valves, Model 9900Quest Medical, Inc.20043
K103551Interlink S / Clearlink System / V-Link Lad with Vitalshield Protective Coating Non-Dehp…Baxter Healthcare Corp20110

Has anything in its family been recalled? (2 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Sep 9, 2010Not classifiedZ-0158-2011Package design/selectionDuring packaging testing, Baxter observed tears and pinholes in Chevron-style pouches for certain infusion disposable products. The pinholes and tears could compromise the sterile barrier properties of the pouch.
Sep 9, 2010Not classifiedZ-0148-2011Package design/selectionDuring packaging testing, Baxter observed tears and pinholes in Chevron-style pouches for certain infusion disposable products. The pinholes and tears could compromise the sterile barrier properties of the pouch.
Feb 16, 2007Not classifiedZ-0618-2007OtherBaxter has received reports of disconnections/leaks during use of vented Paclitaxel administration sets.
Dec 15, 2005Not classifiedZ-0625-06OtherThe extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
Dec 15, 2005Not classifiedZ-0651-06OtherThe extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
Dec 15, 2005Not classifiedZ-0650-06OtherThe extension sets contain microbore female luers that may crack during use, resulting in leakage of medication or incomplete delivery of medication.
Feb 28, 2005Not classifiedZ-0845-05OtherPossible occlusion of the Clearlink injection site valve due to inadequate silicone lubrication of the slit in the upper seal of the valve.
Apr 28, 2004Not classifiedZ-0193-05OtherInadequate directions for use may have contributed to an increase in infection rates at a small number of customers beginning use of the Clearlink needleless device.
Jul 16, 2003Not classifiedZ-1070-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1157-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1156-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1169-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1167-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1161-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1159-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1158-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1168-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.
Jul 16, 2003Not classifiedZ-1166-03OtherThere are possible pinholes or perforations in the set tubing, caused by damage that occurred during the packaging process.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K112893Clearlink Luer Activated Valve, Clearlink System Non-Dehp Catheter Extension SetsBaxter Healthcare Corporation · 2011 · Cites it directly · ◆ in the 2011 descendants bar of FIG. 11 Class I recall
  • K243529Solution Administration SetsBaxter Healthcare Corporation · 2025 · 3 generations on · ◆ in the 2025 descendants bar of FIG. 11 Class I recall

What does this lineage say?

  • Of its descendants, K120443 (Baxter Healthcare Corporation - Renal Division, 2012) has gone furthest, with 28 descendants of its own.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—
Cite this page

510(k) Report. “K003225: Solution Administration Sets with Capless Luer Activated Valve.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K003225

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026